Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Data as at: 10/07/2025
In
Objective
To achieve a high level of capital growth by investing worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector.
AIC sector
Management group
Company website
Launch date
28/04/1995
March
Domicile
United Kingdom
Fund manager
Sven H. Borho, Trevor M. Polischuk
Dividend frequency
Semi-Annually
Wind-up provisions
Shareholders have approve the continuance of the Company as an investment trust for a further period of five years. Continuation vote at every fifth AGM, the next of which will be in 2029.
Continuation vote
5 yearly
Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
---|---|---|---|---|---|---|---|---|
1,423.76 | 1,533.26 | 308.00 | 328.45 | -6.23 | 0 | 0.78 | Jun, Nov | 0.9 (31/03/2024) |
Scroll
Dividends
Dividends declared in last 12 months
Ex-dividend date | Payment date | Dividend amount | Special dividend | Financial year |
---|---|---|---|---|
12/06/2025 | 23/07/2025 | 1.700 | No | 2025 |
28/11/2024 | 09/01/2025 | 0.700 | No | 2025 |
Scroll
Performance (%)
Return type | 1 year | 3 years | 5 years | 10 years | |
---|---|---|---|---|---|
Worldwide Healthcare Trust | Share price total return | -14.4 | -2.6 | -10.7 | 70.3 |
Biotechnology & Healthcare AIC sector | Share price total return | -14.6 | -15.8 | -26.6 | 37.5 |
Scroll
Share structure
Number of shares
462,261,330
139,403,870
Traded volumes (number of shares)
Yesterday | 1 month | 1 year | 5 years | |
---|---|---|---|---|
Total | 1,943,395 | 47,037,855 | 338,106,356 | 1,511,216,056 |
Average | N/A | 2,138,080 | 1,336,390 | 1,198,430 |
Scroll
Traded values (m)
Yesterday | 1 month | 1 year | 5 years | |
---|---|---|---|---|
Total | 5.99 | 141.42 | 1,088.00 | 5,027.70 |
Average | N/A | 6.43 | 4.30 | 3.99 |
Scroll
Trading details
Top holdings
Data as at : 31/03/2025
Investment | % of total assets |
---|---|
Eli Lilly and Co | 11.2 |
Boston Scientific Corp | 10.3 |
AstraZeneca PLC | 7.1 |
Intuitive Surgical Inc | 5.3 |
Stryker Corp | 5.1 |
UnitedHealth Group Inc | 4.6 |
Edwards Lifesciences Corp | 4.1 |
Pfizer Inc | 3.8 |
argenx SE ADR | 3.4 |
Other Assets And Liabilities | -4.7 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.